7WCP
VRTX icon

71 West Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

71 West Capital Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$696K Buy
1,558
+358
+30% +$167K 0.03% 125
2025
Q4 		$544K Buy
+1,200
New +$517K 0.03% 135

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

71 West Capital Partners's VRTX Position: Q1 2026 in Review

71 West Capital Partners increased its Vertex Pharmaceuticals (VRTX) stake by 30% in Q1 2026, buying an estimated $167K and bringing the position to 1,558 shares worth $696K. The position accounts for 0.03% of the portfolio, ranked #125.

71 West Capital Partners first reported a position in VRTX in Q4 2025 and has held it in 2 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • 71 West Capital Partners held 1,558 shares of Vertex Pharmaceuticals worth $696K as of Q1 2026.
  • 71 West Capital Partners bought 358 Vertex Pharmaceuticals shares in Q1 2026, an estimated $167K.
  • Vertex Pharmaceuticals made up 0.03% of 71 West Capital Partners's portfolio in Q1 2026, its #125 holding.
  • 71 West Capital Partners first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on 71 West Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.